Thavandiran, 2019 - Google Patents
Design of Human Pluripotent Stem Cell-derived Cardiac Microtissue-based Platforms for Functional ScreeningThavandiran, 2019
View PDF- Document ID
- 6508368696384795620
- Author
- Thavandiran N
- Publication year
External Links
Snippet
The improved ability to study heart development, disease, and drug response using high- content engineered heart tissue models would expedite the advancement of strategies to overcome heart disease. To meet this challenge, we created microfabricated platforms to …
- 230000000747 cardiac effect 0 title abstract description 199
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/28—Vascular endothelial cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tenreiro et al. | Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering | |
Yang et al. | High-throughput methods in the discovery and study of biomaterials and materiobiology | |
US10034738B2 (en) | Cardiac tissue constructs and methods of fabrication thereof | |
Smith et al. | Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening | |
Cho et al. | Reconstructing the heart using iPSCs: Engineering strategies and applications | |
Mathur et al. | In vitro cardiac tissue models: current status and future prospects | |
Grosberg et al. | Muscle on a chip: in vitro contractility assays for smooth and striated muscle | |
US9512396B2 (en) | In vitro microphysiological system for high throughput 3D tissue organization and biological function | |
Boudou et al. | A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues | |
US20210371782A1 (en) | Methods for optical micropatterning of hydrogels and uses thereof | |
Thavandiran | Design of Human Pluripotent Stem Cell-derived Cardiac Microtissue-based Platforms for Functional Screening | |
Yang et al. | Cardiac organoid: Multiple construction approaches and potential applications | |
Gowran et al. | Young at heart: Pioneering approaches to model nonischaemic cardiomyopathy with induced pluripotent stem cells | |
Stempien et al. | Influence of Remodeled ECM and Co-culture with iPSC-Derived Cardiac Fibroblasts on the Mechanical Function of Micropatterned iPSC-Derived Cardiomyocytes | |
Zhao | Biowire II Platform: High Fidelity Heart-on-a-chip for Drug Screening and Disease Modeling | |
US20180044640A1 (en) | Contractile cellular construct for cell culture | |
Tadevosyan | Heart-on-a-chip as biomimetic platform for cardiac physiology and drug toxicity testing | |
Besser | Engineering a Compartmentalized Hydrogel Platform for In Vitro Assembly of Neuromuscular Junctions | |
Jiao | Engineering of Functional, Striated Muscle Tissues with Controllable 3D Architectures Using a Novel, Thermoresponsive, Nanofabricated Substratum | |
Ahrens | Programming Complex Alignment in Engineered Cardiac Tissue | |
Suddhapas | Fabrication of 3D tissue constructs using standing post platform | |
Tokuno et al. | Induction of Anisotropic Orientation and Enhancement of Gene Functional Expression of Human Pluripotent Stem Cell-Derived Cardiomyocytes Cultured on Nanofabricated Substrates Consisting of Micron Planar Lines and Nano Dot Structures. | |
Dou | Mechanical Measurement and Stimulation of Human Pluripotent Stem Cell-Derived Cardiomyocytes | |
Wang | Engineering Temporal and Spatial Complexity in Biomaterial Scaffolds for Cardiac Disease Modeling and Mechanobiology | |
Renganathan et al. | Mechanical stimulator for tissue-engineered skeletal muscle |